Labmaster participates Interreg’s BIC BRIDGE project
Duration: 1.10.2020 – 30.6.2021
Project coordinator: Ideklinikken, Aalborg University Hospital
Project partners: Turku Science Park Ltd, University of Turku, Labmaster Oy, Tartu BT Park OÜ, BioCon Valley® GmbH, Wroclaw Technology Park, Dianox APS and EATIS.
Funding: Project is funded by Interreg Baltic Sea Region with a total budget of 755 000 €.
Project in a nutshell: Only a small fraction of all biomarker inventions progress to a commercial product: a diagnostic test for clinical use. The BIC (Biomarker Commercialization, 2017-2020) project aimed to promote the commercialization of these inventions and developed tools for researchers, supporting especially the early stages of product development. The BIC BRIDGE follow-up project complements the biomarker commercialization tools developed in the BIC project: develops guidance on the final stages of commercialization and product launch (TRL7-TRL9), identifies necessary training packages (business skills, quality systems, etc.), and describes a biomarker commercialization roadmap, based on the newest EU guidelines. The results of the project will be beneficial for companies, researchers, and technology transfer offices.
Labmaster’s role in the project: Development of the “Technical and Clinical Evaluation” and “Commercial Evaluation” tracks for the Phases “6. Industrial assay development” and “7. Commercial launch and clinical implementation”.
Further information: https://biomarker.nu/
Watch the video: BIC BRIDGE Introduction
Contact person in Labmaster Ltd: email@example.com
Tel. +358 22 760 555
Rauhalinnantie 31, 20780 KAARINA, Finland
Products designed, developed and manufactured by Labmaster Ltd. meet their specifications when stored, used and transported according to the instructions for use and product inserts. Labmaster LUCIA™ is a trademark designed and owned by Labmaster Ltd.
Not all products are available in all regions. Check with your local representative for availability in specific markets.